» Articles » PMID: 36820060

Multifunctional Nano-Realgar Hydrogel for Enhanced Glioblastoma Synergistic Chemotherapy and Radiotherapy: A New Paradigm of an Old Drug

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2023 Feb 23
PMID 36820060
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Realgar, as a kind of traditional mineral Chinese medicine, can inhibit multiple solid tumor growth and serve as an adjuvant drug in cancer therapy. However, the extremely low solubility and poor body absorptive capacity limit its application in clinical medicine. To overcome this therapeutic hurdle, realgar can here be fabricated into a nano-realgar hydrogel with enhanced chemotherapy and radiotherapy (RT) ability. Our objective is to evaluate the superior biocompatibility and anti-tumor activity of nano-realgar hydrogel.

Methods: We have successfully synthesized nano-realgar quantum dots (QDs) coupling with 6-AN molecules (NRA QDs) and further encapsulated with a pH-sensitive dextran hydrogel carrier with hyaluronic acid coating (DEX-HA gel) to promote bioavailability, eventually forming a multifunctional nano-realgar hydrogel (NRA@DH Gel). To better investigate the tumor therapy efficiency of the NRA@DH Gel, we have established the mice in situ bearing GL261 brain glioblastoma as animal models assigned to receive intratumor injection of NRA@DH Gel.

Results: The designed NRA@DH Gel as an antitumor drug can not only exert the prominent chemotherapy effect but also as a "sustainable reactive oxygen species (ROS) generator" can inhibit in the pentose phosphate pathway (PPP) metabolism and reduce the production of nicotinamide adenine dinucleotide phosphate (NADPH), thereby inhibiting the conversion of glutathione disulfide (GSSG) to glutathione (GSH), reducing GSH concentrations in tumor cells, triggering the accumulation of ROS, and finally enhancing the effectiveness of RT.

Conclusion: Through the synergistic effect of chemotherapy and RT, NRA@DH Gel effectively inhibited the proliferation and migration of tumor cells, suppressed tumor growth, improved motor coordination, and prolonged survival in tumor-bearing mice. Our work aims to improve the NRA@DH Gel-mediated synergistic chemotherapy and RT will endow a "promising future" for the old drug in clinically comprehensive applications.

Citing Articles

Harnessing Arsenic Derivatives and Natural Agents for Enhanced Glioblastoma Therapy.

Yuan B, Kikuchi H Cells. 2025; 13(24.

PMID: 39768226 PMC: 11674460. DOI: 10.3390/cells13242138.


Equimolar AsS/FeO Nanocomposites Fabricated by Dry and Wet Mechanochemistry: Some Insights on the Magnetic-Fluorescent Functionalization of an Old Drug.

Shpotyuk O, Lukacova Bujnakova Z, Balaz P, Kovalskiy A, Sznajder M, Cebulski J Materials (Basel). 2024; 17(8).

PMID: 38673084 PMC: 11051269. DOI: 10.3390/ma17081726.


Empagliflozin: a potential anticancer drug.

Wu W, Wang Y, Xie J, Fan S Discov Oncol. 2023; 14(1):127.

PMID: 37436535 PMC: 10338413. DOI: 10.1007/s12672-023-00719-x.

References
1.
Wang H, Liu Z, Gou Y, Qin Y, Xu Y, Liu J . Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway. Int J Nanomedicine. 2015; 10:5505-12. PMC: 4560518. DOI: 10.2147/IJN.S83838. View

2.
Cui Z, Zhang Y, Xia K, Yan Q, Kong H, Zhang J . Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors. Nat Commun. 2018; 9(1):4347. PMC: 6195623. DOI: 10.1038/s41467-018-06749-2. View

3.
Bellinzona M, Roser F, Matthies C, Samii M, Saini M . Biopolymer-mediated suramin chemotherapy in the treatment of experimental brain tumours. Acta Oncol. 2004; 43(3):259-63. DOI: 10.1080/02841860310023129. View

4.
Cheng K, Sano M, Jenkins C, Zhang G, Vernekohl D, Zhao W . Synergistically Enhancing the Therapeutic Effect of Radiation Therapy with Radiation Activatable and Reactive Oxygen Species-Releasing Nanostructures. ACS Nano. 2018; 12(5):4946-4958. DOI: 10.1021/acsnano.8b02038. View

5.
Zhang J, Chen Y, Fang J . Targeting thioredoxin reductase by micheliolide contributes to radiosensitizing and inducing apoptosis of HeLa cells. Free Radic Biol Med. 2022; 186:99-109. DOI: 10.1016/j.freeradbiomed.2022.05.007. View